Korro Bio, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $-9.7M | — |
| FY2017 | — | $-29.6M | — |
| FY2018 | $349.0K | $-48.3M | $42.2M |
| FY2019 | $180.0K | $167.4M | $200.2M |
| FY2020 | — | $192.5M | $220.3M |
| FY2021 | — | $-42.2M | $79.6M |
| FY2022 | — | $-99.0M | $36.3M |
| FY2023 | — | $169.9M | $36.6M |
| FY2024 | — | $160.4M | $55.6M |
| FY2025 | — | $51.4M | $21.8M |